Pomerantz LLP

Please read and download this complaint. When you have finished, continue to Join this ACTION >>

Questions? Contact Us

INC Research Holdings, Inc.

Pomerantz LLP is investigating claims on behalf of investors of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ:  INCR).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether INC Research and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

On August 1, 2017, INC Research and inVentiv Health, Inc. ("inVentiv Health") announced the completion of a merger between the two companies.  On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health.  The Company's combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses.  

On this news, INC Research's share price fell $16.35, or 28.43%, to close at $41.15 on November 9, 2017.